For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

HI-PEITHO

Trial Overview

Official Title

A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versus anticoagulation for acute intermediate-high risk pulmonary embolism: The higher-risk pulmonary embolism thrombolysis study.

Study Purpose

To assess whether ultrasound-facilitated, catheter-directed, thrombolysis and anticoagulation are associated with a significant reduction in the composite outcome of pulmonary embolism (PE)-related mortality, cardiorespiratory decompensation or collapse, or nonfatal symptomatic and objectively confirmed recurrence of PE compared to anticoagulation alone within seven days of randomization.

Diagnosis

Acute pulmonary embolism confirmed by CT

Eligibility

Patients must have elevated troponin levels and elevated risk.
Patients who are pregnant, on chronic anticoagulation, have metastatic cancer, stoke within 6 months or active bleeding are not eligible.

Intervention

EkoSonicTM Endovascular System and Anticoagulation

For more information, visit clinicaltrials.gov.

Key Participation Requirements
Gender
All
Age
18-80
Enrollment Status
Available
Phase
Phase IV
Methodist Health System Trial Code
NCT04790370
Related Specialties